ResMed Inc. (RMD) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$209.64
Price Target
$281.29
Target Range
$225.00 — $345.00
Analyst Rating
Buy
Forward P/E19.0x
Trailing P/E22.0x
Forward PEG1.10
Implied Growth+6.6%
Median Target$275.00
Analyst Spread42.7%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$225
+7.3%
Consensus
$281
+34.2%
Bull Case
$345
+64.6%
Valuation Model TargetsConfidence: 81/100
Bear$143
Base$283
Bull$289
RMD Price Target Analysis
Updated May 7, 2026As of May 7, 2026, ResMed Inc. (RMD) has a Wall Street consensus price target of $281.29, based on estimates from 35 covering analysts. With the stock currently trading at $209.64, this represents a potential upside of +34.2%. The company has a market capitalization of $30.54B.
Analyst price targets range from a low of $225.00 to a high of $345.00, representing a 43% spread in expectations. The median target of $275.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 16 analysts rating the stock as a Buy or Strong Buy,14 rating it Hold, and 5 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, RMD trades at a trailing P/E of 22.0x and forward P/E of 19.0x. The forward PEG ratio of 1.10 indicates reasonable valuation for growth. Analysts expect EPS to grow +6.6% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $283.00, with bear and bull scenarios of $143.03 and $288.72 respectively. Model confidence stands at 81/100, indicating high predictability in the company's fundamentals.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+50.7%
Avg Forward P/E16.6x
Peers with Coverage9 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 PHGKoninklijke Philips N.V. | $25.9B | $27.23 | — | — | Hold | 17.6x | 22 |
 ITGRInteger Holdings Corporation | $3.0B | $86.29 | $98.00 | +13.6% | Buy | 13.3x | 14 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 INSPInspire Medical Systems, Inc. | $1.3B | $45.70 | $91.33 | +99.8% | Hold | 24.5x | 27 |
 TNDMTandem Diabetes Care, Inc. | $1.2B | $18.03 | $31.62 | +75.4% | Buy | — | 39 |
 MDTMedtronic plc | $99.5B | $77.60 | $109.50 | +41.1% | Buy | 14.1x | 49 |
 SYKStryker Corporation | $112.0B | $292.33 | $403.69 | +38.1% | Buy | 19.5x | 50 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
 ZBHZimmer Biomet Holdings, Inc. | $16.2B | $82.83 | $97.90 | +18.2% | Hold | 9.8x | 42 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
Upside Potential Comparison
NVCRINSPTNDMBSXMDTSYKZBHITGRFull RMD Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See RMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs RMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare RMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonRMD — Frequently Asked Questions
Quick answers to the most common questions about buying RMD stock.
What is the RMD stock price target for 2026?
The consensus Wall Street price target for RMD is $281.29, representing 34.2% upside from the current price of $209.64. With 35 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
Is RMD a buy, sell, or hold?
RMD has a consensus rating of "Buy" based on 35 Wall Street analysts. The rating breakdown is mixed, with 14 Hold ratings making up the largest segment. The consensus 12-month price target of $281.29 implies 34.2% upside from current levels.
Is RMD stock overvalued or undervalued?
With a forward P/E of 19.0264x, RMD trades at a relatively low valuation. The consensus target of $281.29 implies 34.2% appreciation, suggesting meaningful undervaluation.
How high can RMD stock go?
The most bullish Wall Street analyst has a price target of $345 for RMD, while the most conservative target is $225. The consensus of $281.29 represents the median expectation. Our quantitative valuation model projects a bull case target of $289 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover RMD stock?
RMD is heavily covered by Wall Street, with 35 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 16 have Buy ratings, 14 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the RMD stock forecast?
The 12-month RMD stock forecast based on 35 Wall Street analysts shows a consensus price target of $281.29, with estimates ranging from $225 (bear case) to $345 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $283, with bear/bull scenarios of $143/$289.
What is RMD's fair value based on fundamentals?
Our quantitative valuation model calculates RMD's fair value at $283 (base case), with a bear case of $143 and bull case of $289. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 81/100.
What is RMD's forward P/E ratio?
RMD trades at a forward P/E ratio of 19.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 22.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy RMD stock?
Wall Street analysts are very optimistic on RMD, with a "Buy" consensus rating and $281.29 price target (34.2% upside). 16 of 35 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do RMD price targets vary so much?
RMD analyst price targets range from $225 to $345, a 43% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $281.29 consensus represents the middle ground. Our model's $143-$289 range provides an independent fundamental perspective.